Adding pembrolizumab (Keytruda) to concurrent chemoradiotherapy in patients with high-risk locally advanced cervical cancer does not harm quality of life, according to patient-reported outcome analyses from […]

TOPLINE: Vitamin D serum levels of ≥ 40 ng/mL may exert a protective effect against breast cancer, according to a new, integrative review of the medical […]

TOPLINE: The Breast Cancer Index (BCI) test assay could help physicians alter their extended endocrine therapy recommendations for patients with hormone receptor (HR)–positive breast cancer and […]

The US Food and Drug Administration (FDA) has granted accelerated approval for lisocabtagene maraleucel (liso-cel) for the treatment of certain adults with relapsed or refractory chronic […]

FREDERICK, Maryland (Reuters) – Gilead Sciences will be able to quadruple production of its cell therapy cancer treatments by 2026 due to improvements in the U.S. […]

TOPLINE: In patients with locally advanced cervical cancer receiving chemoradiation, irradiating less than whole uterus led to a low local recurrence rate and less radiation to […]

While the increased risk of cancer in patients with metabolic syndrome is well established by research, the authors of a new study delve deeper by examining […]

The US Food and Drug Administration (FDA) has approved tislelizumab-jsgr (Tevimbra, BeiGene, Ltd.) as second-line monotherapy for certain adult patients with unresectable or metastatic esophageal squamous […]

Targeted treatments, including antibody-drug conjugates and immunotherapy agents, are now standard of care for breast cancer, but there are limited data on the safety of combining […]